Safety, Tolerability, and Pharmacokinetics of Inhaled Virazole Administered Via Air-Jet Nebulizer in Healthy Volunteers
Status:
Completed
Trial end date:
2021-07-12
Target enrollment:
Participant gender:
Summary
This study is a Phase 1a, randomized, double-blind, placebo-controlled, safety, tolerability,
and PK study in healthy adult volunteers.
Participants were screened for eligibility within 14 days prior to enrollment. Four
successive cohorts were enrolled, with each cohort receiving a single dose of Virazole or
placebo using different delivery regimens.